Evidence map›Paper›PMID 23319634›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene.

Melissa N McCracken, Eric H Gschweng, Evan Nair-Gill, Jami McLaughlin, Aaron R Cooper, Mireille Riedinger, Donghui Cheng, Christopher Nosala, Donald B Kohn, Owen N Witte

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Molecular imaging of stem cell therapies in ischemic stroke.European journal of nuclear medicine and molecular imaging · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Review
  7. Review
  8. OncoTargets and therapy · 2020
    Article
  9. New Developments in Imaging Cell-Based Therapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Review
  10. In vivo engineering of bone tissues with hematopoietic functions and mixed chimerism.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2015
    Article
  17. Article
  18. Pre- and postmortem imaging of transplanted cells.International journal of nanomedicine · 2015
    Review
  19. Technology advancement for integrative stem cell analyses.Tissue engineering. Part B, Reviews · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Melissa N McCrackenDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Eric H Gschweng
Evan Nair-Gill
Jami McLaughlin
Aaron R Cooper
Mireille Riedinger
Donghui Cheng
Christopher Nosala
Donald B Kohn
Owen N Witte

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Howard Hughes Medical InstituteNIGMS NIH HHS T32 GM008042
6 · The paper itself

Abstract

Positron emission tomography (PET) reporter genes allow noninvasive whole-body imaging of transplanted cells by detection with radiolabeled probes. We used a human deoxycytidine kinase containing three amino acid substitutions within the active site (hdCK3mut) as a reporter gene in combination with the PET probe [(18)F]-L-FMAU (1-(2-deoxy-2-(18)fluoro-β-L-arabinofuranosyl)-5-methyluracil) to monitor models of mouse and human hematopoietic stem cell (HSC) transplantation. These mutations in hdCK3mut expanded the substrate capacity allowing for reporter-specific detection with a thymidine analog probe. Measurements of long-term engrafted cells (up to 32 wk) demonstrated that hdCK3mut expression is maintained in vivo with no counter selection against reporter-labeled cells. Reporter cells retained equivalent engraftment and differentiation capacity being detected in all major hematopoietic lineages and tissues. This reporter gene and probe should be applicable to noninvasively monitor therapeutic cell transplants in multiple tissues.

Indexed as

AnimalsArabinofuranosyluracilBlotting, WesternCell Line, TumorDeoxycytidine KinaseFemaleFluorine RadioisotopesHematopoietic Stem CellsHematopoietic Stem Cell TransplantationImmunohistochemistryInterleukin Receptor Common gamma SubunitKaplan-Meier EstimateLuminescent ProteinsMiceMice, Inbred C57BLMice, Inbred NODArabinofuranosyluracilclevudineDeoxycytidine KinaseFluorine RadioisotopesIl2rg protein, mouseInterleukin Receptor Common gamma SubunitLuminescent Proteins

Identifiers

PMID23319634
PMCPMC3562822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.